Vietnam Health Cover "Fragmentary"

25 November 1996

Vietnam's health insurance system remains loose and fragmentary, giving rise to disparities in implementation, reports the Vietnam Courier.

Introduced in August 1992, the health insurance services comprise 59 bureaux in all 53 Vietnamese provinces and cities. Cover is compulsory for state employees (including retirees) and employees of enterprises. The premium is 3% of wages, of which 2% is paid by the government. Premiums for voluntary insurance are 40,000-100,000 dong ($3.6-$9.00) a year.

The Vietnam Insurance Company issued over 7 million insurance cards, worth over 400 billion dong ($36.3 million) in 1995, and the estimate for 1996 is 10 million cards worth 500 billion dong. However, a recent survey by the State Inspector of 42 out of the 53 health insurance offices revealed financial deficits of 11% of total revenues. For many offices, it is not clear how premiums have been spent, but only 50.2% of health insurance revenues have been used to pay medical bills, instead of the 90% set by the government. Also, voluntary insurance premiums differ according to location. For example, a child in the mountain provinces pays only 7,000 dong a year, while the amount in Hanoi or Ho Chi Minh City is 40,000 dong.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight